Return to Topic index
 
View Related Resources

Clinical Care Guidelines


Acid
Alcohol
Cocaine
E-Cigarettes
Marijuana
Opiates
Prescription Medication
Tobacco


 

 
Acid
 
The Diagnostic and Statistical Manual of Mental Disorders (DSM-V): Acid
American Psychiatric Association, 2013
The DSM-V is the most comprehensive, current, and critical resource for clinical practice available to today's mental health clinicians and researchers of all orientations. The DSM-V: Acid can be  used by health professionals, social workers, and forensic and legal specialists to diagnose and classify mental disorders.
 
 
Alcohol
 
Helping Patients Who Drink Too Much
National Institute on Alcohol Abuse and Alcoholism, 2005
This Clinician’s Guide provides guidelines for primary care and mental health clinicians on how to help their patients who are at-risk drinkers and or struggling with an alcohol use disorder. It is also available in a Pocket Guide and in Spanish.
 
TIP 49: Incorporating Alcohol Pharmacotherapies Into Medical Practice
Substance Abuse and Mental Health Services Administration, 2009
These clinical practice guidelines provide information for using four medications in the medication-assisted treatment of alcoholism and alcohol abuse: acamprosate, disulfiram, oral naltrexone, and extended-release injectable naltrexone. Also discusses patient management.
 
Alcohol Use by Youth and Adolescents: A Pediatric Concern
American Academy of Pediatrics, 2010
The AAP states the responsibility of pediatricians to be knowledgeable about substance abuse, to be able to recognize risk factors for alcohol and other substance abuse among youth, screen for use, provide appropriate brief interventions, and refer to treatment.
 
The Diagnostic and Statistical Manual of Mental Disorders (DSM-V): Alcohol
American Psychiatric Association, 2013
The DSM-V is the most comprehensive, current, and critical resource for clinical practice available to today's mental health clinicians and researchers of all orientations. The DSM-V: Alcohol can be used by health professionals, social workers, and forensic and legal specialists to diagnose and classify mental disorders.
 
Medication for the Treatment of Alcohol Use Disorder: A Brief Guide
Substance Abuse and Mental Health Services Administration, 2015
These guidelines provide guidance for the use of medication-assisted treatment for alcoholism and alcohol abuse in clinical practice. It summarizes approved medications and discusses screening and patient assessment, treatment planning, and patient monitoring.
 
 
Cocaine
 
TIP 33: Treatment for Stimulant Use Disorder
Substance Abuse and Mental Health Services Administration, 2009
These clinical practice guidelines provide information on the effects of abusing stimulants, on applying validated treatment strategies for stimulant abuse, and treatment considerations for special groups, such as intravenous drug users, gay men, and people with co-occurring disorders.
 
 
E-cigarettes

Electronic Cigarettes: Policy Statement
American Heart Association, 2014
Reviewing the latest science concerning electronic cigarettes, this policy statement also provides an overview on design, operations, constituents, toxicology, safety, user profiles, public health, youth access, impact as a cessation aid, and secondhand exposure.
 
Regulating Electronic Cigarettes​​ and other ENDS​
American Association for Cancer Research, 2015
The AACR with the American Society of Clinical Oncology released a joint statement to guide policy makers in how to best minimize the potential negative consequences of ENDS without undermining their potential use as a smoking cessation tool. 
 
Electronic Cigarettes: Position Statement
Canadian Medical Association, 2015
In the absence of solid evidence of harms or benefits, the sale of e-cigarettes containing nicotine should continue to be banned in Canada. The CMA recommends a ban on the sale of all e-cigarettes to Canadians younger than the minimum age for tobacco consumption.
 
Electronic Cigarettes: Position Statement
Australian Government: National Health and Medical Research Council, 2015
While currently funding research into the safety and efficacy of e-cigarettes for smoking cessation the NNHMRC recommends that health authorities act to minimize harm until evidence of safety, quality, and efficacy can be produced.
 
 
Marijuana
 
Cannabis Youth Treatment Series
Substance Abuse and Mental Health Services Administration, 2001–2008
This five-volume series of guidelines provides clinicians with information for working with adolescent cannabis users.
 
The Diagnostic and Statistical Manual of Mental Disorders (DSM-V): Marijuana
American Psychiatric Association, 2013
The DSM-V is the most comprehensive, current, and critical resource for clinical practice available to today's mental health clinicians and researchers of all orientations. The DSM-V: Marijuana can be used by health professionals, social workers, and forensic and legal specialists to diagnose and classify mental disorders.
 
The Impact of Marijuana Policies on Youth: Clinical, Research, and Legal Update
American Academy of Pediatrics, 2015
This policy statement provides the position of the AAP on the issue of marijuana legalization. The accompanying technical report reviews current evidence about the relationships of marijuana use with health and the developing brain and the legal status of marijuana and adolescents’ use of marijuana to better understand how change in legal status might influence the degree of marijuana use by adolescents in the future.  
Opiates
 
TIP 40: Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction
Substance Abuse and Mental Health Services Administration, 2004
Aimed at helping physicians make decisions about using buprenorphine to treat opioid addiction, these Clinical Guidelines includes information on patient assessment; protocols for opioid withdrawal; and the treatment of pregnant women, teens, and polysubstance users.
 
TIP 43: Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs
Substance Abuse and Mental Health Services Administration, 2008
These guidelines give a detailed description of medication-assisted treatment for addiction to opioids, including comprehensive maintenance treatment, detoxification, and medically supervised withdrawal. It also discusses screening, assessment, and administrative and ethical issues.
 
TAP 30: Buprenorphine: A Guide for Nurses
Substance Abuse and Mental Health Services Administration, 2009
Designed for nurses, this guides provides information about buprenorphine for medication-assisted treatment of addiction to opioids and guidelines for working with physicians to provide office-based screening, assessment, supervised withdrawal (detoxification), and maintenance treatment.
 
An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence
Substance Abuse and Mental Health Services Administration, 2012
This advisory gives an overview of extended-release injectable naltrexone (Vivitrol), a treatment for people with opioid dependence. It also discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit from this treatment.

Opioid Abuse, Dependence, and Addiction in Pregnancy
American College of Obstetricians and Gynecologists, 2012
ACOG provides information on the current standard of care for pregnant women with opioid dependence which is the referral for opioid-assisted therapy with methadone, but also suggests that there is emerging evidence that buprenorphine should be considered.
 
The Diagnostic and Statistical Manual of Mental Disorders (DSM-V): Opiates
American Psychiatric Association, 2013
The DSM-V is the most comprehensive, current, and critical resource for clinical practice available to today's mental health clinicians and researchers of all orientations. The DSM-V: Opiates can be used by health professionals, social workers, and forensic and legal specialists to diagnose and classify mental disorders
 
Federal Guidelines for Opioid Treatment Programs
Substance Abuse and Mental Health Services Administration, 2015
Providing updated information for the operation of opioid treatment programs, these Guidelines cover patient assessment, treatment planning, medication-assisted treatment (methadone and buprenorphine), overdose and relapse prevention, and recovery care.
 
Interagency Guideline on Prescribing Opioids for Pain
Washington State Agency Medical Directors’ Group, 2015
These guidelines expand on the 2009 guidelines to include opioid use in acute, subacute, and perioperative pain phases and in special population. It also includes sections on tapering and opioid use disorder.
 
Clinical Guidelines for Opioid Use
PCSS MAT Training, 2015
These guidelines include extensive resources in managing and monitoring the use of opioids for pain management. 
 
 
Prescription Medications
 
Guide to Good Prescribing
The World Health Organization, 1994
Includes step-by-step guidance to rational prescribing and teaches skills that are not time-limited but which remain valid throughout a clinical career. This guide explains the principles of drug selection and how to develop and become familiar with a set of drugs for regular use in practice. It is available in several languages, including Arabic, French, Korean, Russian, and Spanish.
 
Guidelines for Prescribing Controlled Use, Abuse, Misuse, & Disposal of Prescription Pain Medication Clinical Reference
American College of Preventive Medicine, 2011
This clinical reference guide provides information on the use an abuse of prescription medications, clarifying terminology, the prescribers’ role, physician strategies, and additional resources.
 
Substance for Pain
Medical Board of California, 2014
Intended to help physicians improve outcomes of patient care and to prevent overdose deaths due to opioid use, these guidelines particularly address the use of opioids in the long-term treatment of chronic pain.  

Tobacco
 
VA/DoD Clinical Practice Guidelines: Treating Tobacco Use and Dependence
U.S. Department of Veterans Affairs, 2008
Describing the critical decision points in the Management of Tobacco Use, these Guidelines also provides clear and comprehensive evidence-based recommendations to improve patient outcomes and local management of patients who use tobacco products.
 
Tobacco Use: A Pediatric Disease
American Academy of Pediatrics, 2009
The AAP calls for the elimination of tobacco use and its consequences in the pediatric population, as well as advocacy for policies that protect children from secondhand smoke exposure and the elimination of tobacco use in the media, public places, and homes.
 
Tobacco as a Substance of Abuse
American Academy of Pediatrics, 2009
This technical report presents the critical role of pediatricians in helping to reduce tobacco use and addiction and secondhand tobacco-smoke exposure in the pediatric population. It includes education and prevention, screening and detection, and treatment and referral.
 
The Diagnostic and Statistical Manual of Mental Disorders (DSM-V): Tobacco
American Psychiatric Association, 2013
The DSM-V is the most comprehensive, current, and critical resource for clinical practice available to today's mental health clinicians and researchers of all orientations. The DSM-V: Tobacco can be used by health professionals, social workers, and forensic and legal specialists to diagnose and classify mental disorders. 


The goal of the AHRQ-funded project, Youth Providers 2.0 (YP2.0), is to improve the use of evidence-based practices among health care providers caring for adolescents and young adults. To accomplish this goal, SAHM will engage in a number of activities using new media to improve the dissemination of patient-centered outcomes research (PCOR) to health professionals.
 

More in this Section